PictorLabs, an AI-powered virtual staining technology leader, and Hamamatsu Photonics, a renowned whole slide imaging systems provider, have announced a strategic partnership to develop cutting-edge applications for advancing virtual staining in routine laboratory practices. This collaboration aims to explore the growing demand for efficient, scalable digital pathology solutions.
PictorLabs' technology eliminates the need for toxic reagents and reduces turnaround times compared to traditional chemical stain results. Hamamatsu's NanoZoomer series of whole slide scanners is known for its reproducibility and reliability. The partnership seeks to streamline workflows and accelerate the adoption of digital pathology at an enterprise scale.
This collaboration is expected to revolutionize histopathology by combining PictorLabs' AI-powered virtual staining technology with Hamamatsu's state-of-the-art imaging systems, potentially transforming laboratory practices and improving outcomes in research, pharma, and clinical applications.